Instrument Inactif

Agenda ChemoCentryx, Inc.

Actions

CCXI

US16383L1061

Graphique agenda ChemoCentryx, Inc.

a35160a10.qA5ynEA1WXxkH7RnBAO6GYOkV2mslhK0g-Q9jf3WMRI.2UYnzHdzNkpde_orNWf5XM31ZQDW-V_z0Idf-ZOSQX3AWgH_Dww8CTJM2w~a8eaf6bba7f089901d512b9fddc534b6

Evénements à venir sur ChemoCentryx, Inc.

Aucun évènement disponible

Evénements passés sur ChemoCentryx, Inc.

13/11/2022 16:15 American College of Rheumatology Convergence Conference - Abstract #1077
13/11/2022 16:10 American College of Rheumatology Convergence Conference - Abstract #1076
13/11/2022 15:00 American College of Rheumatology Convergence Conference - Abstract #1078
10/11/2022 21:15 American College of Rheumatology Convergence Conference - Abstract #525
10/11/2022 17:40 Society for Immunotherapy of Cancer Meeting - Abstract Number: 499
10/11/2022 17:40 Society for Immunotherapy of Cancer Meeting - Abstract Number: 769
05/11/2022 15:00 American Society of Nephrology Kidney Conference - Abstract #SA-PO696
05/11/2022 15:00 American Society of Nephrology Kidney Conference - Abstract #SA-PO633
04/11/2022 15:00 American Society of Nephrology Kidney Conference - Abstract #FR-PO651
18/10/2022 Assemblée extraordinaire - M&A Vote
08/09/2022 Rheumatology Advanced Practice Providers National Conference
08/09/2022 Medscape LIVE! Perspectives in Rheumatic Diseases Conference
27/08/2022 07:30 European Meeting on Complement in Human Disease
09/08/2022 Premier semestre 2022 Publication de résultats Après clôture
22/06/2022 European Society for Pediatric Nephrology Conference
05/06/2022 15:00 American Society of Clinical Oncology Meeting - Abstract No 2593
02/06/2022 10:35 European Alliance of Associations for Rheumatology Conference - Oral Presentation No OP0180
01/06/2022 13:36 European Alliance of Associations for Rheumatology Conference - Poster No POS0835
01/06/2022 13:20 European Alliance of Associations for Rheumatology Conference - Poster No POS0833
26/05/2022 19:00 Assemblée générale
  1. Bourse
  2. Actions
  3. Action CCXI
  4. Agenda ChemoCentryx, Inc.